Lucintel Forecasts The Global Clinical Trial Imaging Market To Reach $2 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7699
Comment this article

According to a market report by Lucintel, the future of the global clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2 billion by 2030, at a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.
A more than 150-page report to understand trends, opportunity and forecast in global clinical trial imaging market to 2030 by product & services (software and services), modality (computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, and echocardiography), therapeutic area (oncology, infectious diseases, neurology, CVS, endocrinology, and immunological disorder), end use (pharmaceutical companies, biotechnology companies, medical device manufacturer, contract ...
... research organizations, academic and government research institutes, and others),and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.
Within this market, pharmaceutical companies will remain the largest segment due to increasing demand for new treatments and medications aimed at addressing chronic diseases.
Download sample by clicking on clinical trial imaging market.
North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in R&D in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north America. North America also performs the maximum number of clinical trials.
ICON, Biotelemetry, Medpace Holdings, Biomedical Systems Corporation, Bioclinica, IXICO, Resonance Health, Radiant Sage, Intrinsic Imaging, Cardiovascular Imaging Technologies are the major suppliers in the clinical trial imaging market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hermetic Reciprocating Refrigerator Compressor Market
Hybrid & Electric Vehicle Fuse Market
Industrial Truck Market
Motor for Humanoid Robot Market
Overhead Travelling Cleaner (OHTC) Market